Skip to main content
OpenTrials
Completed

NCT Number: NCT00932919

Thought Field Therapy and Cognitive Therapy for Agoraphobia

The purpose for this study is to find out if Thought field therapy has the same effect as, or better effect than, Cognitive therapy for Agoraphobia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sorlandet Hospital

Arendal, 4809, Norway

About this study

Thought field therapy is an alternative treatment method that has shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 72 patients will be randomized to three groups. 24 patients will receive cognitive therapy as a control method, 24 patients will receive thought field therapy. The remaining 24 patients will wait three months, and then be randomized to either of the two therapies.

Before inclusion all patients will be diagnosed with M.I.N.I. and SCID II. They will fill out self evaluation forms for symptoms and quality of life, before and after treatment, and one year after treatment.

All patients will undergo an interview with ADIS on panic and agoraphobic diagnosis and symptoms before starting treatment, and on panic and agoraphobic symptoms immediately after and one year after treatment. These interviews will be done by psychologists who are blinded for which type of treatment the patients have got.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients ages 18 years or older,
  • Patients with agoraphobia,
  • Patients with a score on Mobility Inventory "Alone" of 2.5 or more,
  • Patients who give a written consent to participate.

Exclusion criteria

  • Psychosis (past or present),
  • Drug abuse or dependency,
  • Moderate or high score on suicidal behaviour on the M.I.N.I.,
  • Patients who have another illness (other than panic disorder or agoraphobia) and are in need of immediate treatment.

Treatment and study plan

Thought field therapy

Behavioral

5 sessions with Thought field therapy

Other names: TFT

cognitive therapy

Behavioral

12 sessions of Cognitive therapy

Other names: CBT

Wait list

Behavioral

3 months waiting, then randomized to either thought field therapy or cognitive therapy

Other names: WL

Primary outcomes

  1. Change in agoraphobic situation scores in ADIS.

    Time frame: Immedeately and 12 months after treatment

Secondary outcomes

  1. Interference score in ADIS

    Time frame: Immediately and 12 months after treatment

  2. Mobility Inventory

    Time frame: Immediately and 12 months after treatment

  3. Agoraphobic Cognitions Questionnaire

    Time frame: Immediately and 12 months after treatment

  4. Body Sensations Questionnaire

    Time frame: Immediately and 12 months after treatment

  5. BDI

    Time frame: Immediately and 12 months after treatment

  6. BAI

    Time frame: Immediately and 12 months after treatment

  7. WHOQOL-BREF

    Time frame: Immediately and 12 months after treatment

  8. SF-36

    Time frame: Immediately and 12 months after treatment

  9. Safety Seeking Behaviours Questionnaire.

    Time frame: Immediately and 12 months after treatment

  10. Panic scale

    Time frame: Immediately and 12 months after treatment

Sponsors and collaborators

Lead sponsor

Sorlandet Hospital HF

Other Gov

Registry information

Official study title

Thought Field Therapy and Cognitive Therapy for Agoraphobia - a Randomized Controlled Intervention Study Where the Efficacy of Thought Field Therapy is to be Compared to Cognitive Therapy

Important dates

Study start
2006
Primary completion
2010
Study completion
2010
First posted
Jul 7, 2009
Registry last updated
Apr 23, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.